- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-3329
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma ; volume:2 ; number:1 ; day:24 ; month:1 ; year:2012 ; pages:1-7 ; date:12.2012
Clinical Sarcoma Research ; 2, Heft 1 (24.1.2012), 1-7, 12.2012
- Urheber
-
Katz, Daniela
Boonsirikamchai, Piyaporn
Choi, Haeson
Lazar, Alexander J.
Wang, Wei-Lein
Xiao, Lianchun
Park, Min S.
Ravi, Vinod
Benjamin, Robert S.
Araujo, Dejka M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/2045-3329-2-2
- URN
-
urn:nbn:de:101:1-2021081922245295099002
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Katz, Daniela
- Boonsirikamchai, Piyaporn
- Choi, Haeson
- Lazar, Alexander J.
- Wang, Wei-Lein
- Xiao, Lianchun
- Park, Min S.
- Ravi, Vinod
- Benjamin, Robert S.
- Araujo, Dejka M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
AIH Therapy: Beyond First-Line
Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures
Complete Remission of Recurrent Retroperitoneal Liposarcoma after the Administration of Gemcitabine and Docetaxel as First-Line Adjuvant Chemotherapy: A Case Report
Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
Liposarcoma paratesticular gigante
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
AIH Therapy: Beyond First-Line
Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures
Complete Remission of Recurrent Retroperitoneal Liposarcoma after the Administration of Gemcitabine and Docetaxel as First-Line Adjuvant Chemotherapy: A Case Report
Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
Liposarcoma paratesticular gigante
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
AIH Therapy: Beyond First-Line
Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures
Complete Remission of Recurrent Retroperitoneal Liposarcoma after the Administration of Gemcitabine and Docetaxel as First-Line Adjuvant Chemotherapy: A Case Report
Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model